Balu DT - Search Results

1

History of the Concept of Disconnectivity in Schizophrenia.

Coyle JT, Balu DT, Puhl MD, Konopaske GT. Coyle JT, et al. Among authors: balu dt. Harv Rev Psychiatry. 2016 Mar-Apr;24(2):80-6. doi: 10.1097/HRP.0000000000000102. Harv Rev Psychiatry. 2016. PMID: 26954593 Free PMC article. Review.

2

Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.

Balu DT, Coyle JT. Balu DT, et al. Neurosci Biobehav Rev. 2011 Jan;35(3):848-70. doi: 10.1016/j.neubiorev.2010.10.005. Epub 2010 Oct 15. Neurosci Biobehav Rev. 2011. PMID: 20951727 Free PMC article. Review.

3

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia.

Coyle JT, Balu D, Benneyworth M, Basu A, Roseman A. Coyle JT, et al. Dialogues Clin Neurosci. 2010;12(3):359-82. doi: 10.31887/DCNS.2010.12.3/jcoyle. Dialogues Clin Neurosci. 2010. PMID: 20954431 Free PMC article. Review.

4

Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology.

DeVito LM, Balu DT, Kanter BR, Lykken C, Basu AC, Coyle JT, Eichenbaum H. DeVito LM, et al. Among authors: balu dt. Genes Brain Behav. 2011 Mar;10(2):210-22. doi: 10.1111/j.1601-183X.2010.00656.x. Epub 2010 Nov 2. Genes Brain Behav. 2011. PMID: 21029376 Free PMC article.

5

Glutamate receptor composition of the post-synaptic density is altered in genetic mouse models of NMDA receptor hypo- and hyperfunction.

Balu DT, Coyle JT. Balu DT, et al. Brain Res. 2011 May 25;1392:1-7. doi: 10.1016/j.brainres.2011.03.051. Epub 2011 Apr 12. Brain Res. 2011. PMID: 21443867 Free PMC article.

6

The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex.

Balu DT, Basu AC, Corradi JP, Cacace AM, Coyle JT. Balu DT, et al. Neurobiol Dis. 2012 Feb;45(2):671-82. doi: 10.1016/j.nbd.2011.10.006. Epub 2011 Oct 17. Neurobiol Dis. 2012. PMID: 22024716 Free PMC article.

7

Neuronal D-serine regulates dendritic architecture in the somatosensory cortex.

Balu DT, Coyle JT. Balu DT, et al. Neurosci Lett. 2012 May 31;517(2):77-81. doi: 10.1016/j.neulet.2012.04.020. Epub 2012 Apr 12. Neurosci Lett. 2012. PMID: 22521586 Free PMC article.

8

Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Coyle JT, Basu A, Benneyworth M, Balu D, Konopaske G. Coyle JT, et al. Handb Exp Pharmacol. 2012;(213):267-95. doi: 10.1007/978-3-642-25758-2_10. Handb Exp Pharmacol. 2012. PMID: 23027419 Free PMC article. Review.

9

Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.

Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, Takagi S, Bolshakov VY, Coyle JT. Balu DT, et al. Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):E2400-9. doi: 10.1073/pnas.1304308110. Epub 2013 May 31. Proc Natl Acad Sci U S A. 2013. PMID: 23729812 Free PMC article.

10

D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.

Santini MA, Balu DT, Puhl MD, Hill-Smith TE, Berg AR, Lucki I, Mikkelsen JD, Coyle JT. Santini MA, et al. Among authors: balu dt. Behav Brain Res. 2014 Feb 1;259:242-6. doi: 10.1016/j.bbr.2013.11.022. Epub 2013 Nov 20. Behav Brain Res. 2014. PMID: 24269270 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters